Could an immune therapy ease long COVID brain fog?
NCT ID NCT05350774
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 31 times
Summary
This study tests whether a treatment called IVIG (human immunoglobulin) can help with ongoing brain and nerve symptoms after COVID-19, such as dizziness, memory problems, or weakness. About 45 adults who had COVID-19 at least 12 weeks ago will receive either IVIG or a placebo (saline) for 5 days, then switch to the other option. The goal is to see if IVIG improves quality of life and reduces Long COVID symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC INFLAMMATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.